Perimeter Medical Imaging to Reveal Q3 2026 Financial Results in Upcoming Conference Call

Perimeter Medical Imaging to Host Q3 2026 Financial Conference Call



Perimeter Medical Imaging AI, Inc., a key player in the medical technology sector, has announced an important event for its investors and stakeholders. The company is set to report its financial and operational results for the third quarter of 2026 on November 24, 2026. This reporting comes shortly before the markets open, making it a significant occasion for investors eager for insights into the company's performance.

Conference Call Details


Following the results announcement, Perimeter's management will hold a conference call to discuss the financial outcomes and provide updates on corporate developments. This session is an opportunity for investors to gain a deeper understanding of the company’s current position and future direction.

Date: Tuesday, November 24, 2026
Time: 8:30 AM Eastern Time
Dial-In Numbers:
  • - U.S. & Canada: 1-800-717-1738
  • - International: 1-646-307-1865

The call will also be available for live streaming and archived on the company’s website, ensuring that stakeholders can access this essential information at their convenience.

About Perimeter Medical Imaging AI, Inc.


Perimeter, with its bases in Toronto, Canada, and Dallas, Texas, is dedicated to transforming cancer surgery through innovative imaging technology. Their flagship product, the Claire OCT System, is designed to deliver ultra-high-resolution and real-time imaging solutions to assist surgeons in evaluating tissue excised during cancer procedures. Recently approved by the U.S. Food and Drug Administration (FDA), the Claire system utilizes artificial intelligence to enhance the detection of suspicious areas in breast tissue, marking a significant technological advancement in cancer surgical practices.

Claire OCT System Explained


The Claire OCT System serves as a revolutionary tool in the surgical realm, providing three-dimensional imaging that aids healthcare professionals in visualizing excised lumpectomy tissue. By combining volumetric cross-sectional imaging with AI-driven detection algorithms, it supports doctors in identifying critical areas requiring further attention. However, it's important to note that the Claire system is meant to complement, not replace, standard histopathology assessments.

Forward-Looking Statements


As Perimeter prepares to share its Q3 results, the company reiterates that its statements may contain forward-looking information. This information is subject to inherent risks and uncertainties, and actual results can differ from those anticipated. These statements include projections of financial performance, and any claims of future advancements in product development.

In shaping its future direction, Perimeter relies on its commitment to innovation, patient care, and expanded access to cutting-edge medical technologies. By fostering an environment of scientific inquiry and operational excellence, the company aims to enhance outcomes for patients undergoing cancer treatment.

For investors interested in staying updated with Perimeter Medical Imaging, participating in the conference call on November 24 promises to be an enlightening experience. Additionally, comprehensive insights can be found on the company’s official SEDAR+ profile, detailing their operational metrics and strategic vision moving forward.

For more information, stakeholders may reach out to investor relations representatives or visit Perimeter’s website for the latest updates and releases.

  • ---
This article underscores the significance of the scheduled financial call while detailing the innovative offerings of Perimeter Medical Imaging in the healthcare space. As the company continues to pave the way in cancer surgery imaging, stakeholders are encouraged to remain engaged.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.